select trial semaglutide results Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial Semaglutide in Patients With Obesity

While Mounjaro is not officially approved for weight loss, it plays a significant role in managing blood sugar levels for those who have been diagnosed with type 2 diabetes

FDA-approved obesity medications (OMs) are safe, evidence-based therapies that target specific physiology to improve the disease and are most effective when used as part of a comprehensive treatment plan

I just didnt feel like myself

Slower Digestion: Semaglutide delays gastric emptyingthe rate at which food leaves the stomachallowing individuals to feel full longer after meals

But based on the results of our analysis, the body weight loss was greater in GLP-1RA/SGLT-2i combination therapy whether compared to GLP-1RA monotherapy or compared to SGLT-2i monotherapy